Sound journalism, grounded in facts and Biblical truth

FDA report: Single-dose vaccine safe and effective

Vials of the Johnson & Johnson COVID-19 vaccine Associated Press/Johnson & Johnson (file)

FDA report: Single-dose vaccine safe and effective

Johnson & Johnson’s COVID-19 shot is about 66 percent effective against moderate to severe illness and 85 percent effective at preventing severe cases. U.S. Food and Drug Administration scientists on Wednesday also said the single-dose vaccine is safe, paving the way for the agency’s advisers to meet on Friday to debate whether to grant emergency use authorization.

How is vaccine distribution going elsewhere? The United Nations’ COVAX initiative made its first delivery on Wednesday. Ghana received 600,000 doses of the AstraZeneca vaccine for free and plans to start vaccinations on March 2. Some 92 countries are also in line for shots through the program, while 90 other nations and eight territories pick up the bill. COVAX plans to provide enough vaccines for participant countries to immunize 20-30 percent of the population, but it has already hit delays and shortages. The Ivory Coast is set to receive the next batch.

Dig deeper: Read Mindy Belz’s report about poor nations’ struggle to acquire COVID-19 vaccines as richer countries buy them up.

Rachel Lynn Aldrich Rachel is an assistant editor for WORLD Digital. She is a Patrick Henry College and World Journalism Institute graduate. Rachel resides with her husband in Wheaton, Ill.


Please wait while we load the latest comments...


Please register or subscribe to comment on this article.

Steve Shive

If this were truly a free market and people had the option of choosing which vaccine how many would pick a vaccine that may offer only 66% protection and at best 85%? When there are two others out there that offer over 90%. In everyday parlance we call JnJ's vaccine a "Me too" Drug. It wolud be impossible to sell.

Add this to the list of questions about vaccines that were able to avoid full clinical trials and were brought "to market" under an EUA. This is a Global concern about choice, and about informed consent. And furthermore there is the issue of herd immunity which was recently brought out in the WSJ's interview with Johns Hopkins' Professor Makary who said, "Some medical experts privately agreed with my prediction that there may be very little Covid-19 by April but suggested that I not to talk publicly about herd immunity because people might become complacent and fail to take precautions or might decline the vaccine. But scientists shouldn’t try to manipulate the public by hiding the truth. As we encourage everyone to get a vaccine, we also need to reopen schools and society to limit the damage of closures and prolonged isolation. Contingency planning for an open economy by April can deliver hope to those in despair and to those who have made large personal sacrifices."